Newcastle Gut Club
Cholestatic Liver Diseases and the
Cross-Over into IBD

Meeting Details

DATE & TIME
7:00pm – 9:15pm Thursday 22 May 2025
Crystalbrook Kingsley
Coal River Room, 282 King Street, Newcastle, NSW 2300
REGISTER NOW

Presented by:

Speaker-02
A/Prof Martin Weltman
Director of the Gastroenterology and Hepatology Department, Nepean Public Hospital, Kingswood, NSW.

AGENDA

TIME
TOPIC
6:30pm
Arrival
7:00pm
Welcome and introduction
7:15pm
Creating a new paradigm for PBC treatment: identifying and addressing challenges
8:20pm
2025 EASL and APASL updates
9:00pm
Final discussion, Q&A and closing remarks
Dinner will be served during meeting.
REGISTER NOW

RSVP: Please RSVP by Tuesday 13th May 2025

Parking: On street parking available

Contact: Niki Carfino 0401 955 399 or niki.carfino@drfalkpharma.com.au

SPEAKER

Speaker-02
A/Prof Martin Weltman
Director of the Gastroenterology and Hepatology Department, Nepean Public Hospital, Kingswood, NSW.
No Biographies

REGISTRATION FORM

UNFORTUNATELY THIS EVENT IS CLOSED

Please direct any questions to Niki Carfino 0401 955 399 or niki.carfino@drfalkpharma.com.au

After registering, you will receive a confirmation email which can be saved directly into your calendar.

This meeting is for Healthcare Professionals only. In registering for this meeting, I understand that Personal information collected from me by Dr Falk Pharma Australia when I respond to this invitation will be used for communication about this meeting and other Dr Falk Pharma Australia initiatives. Your personal information will be treated in accordance with applicable laws and in accordance with Dr Falk Pharma Australia policies. For more information, please contact our Privacy Officer by email at privacy@drfalkpharma.com.au or phone 1800 373 255. Copyright © 2025 Dr Falk

Dr. Falk Pharma Australia Pty Ltd. ABN 40 631 091 131. 9 Help Street, Chatswood NSW 2067. Website: www.drfalkpharma.com.au Tel: 1800 DRFALK (1800 373 255). Email: admin@drfalkpharma.com.au
Date of preparation: April 2025. DRF357. CLD-2025-1482.